Literature DB >> 20540117

EAE mediated by a non-IFN-γ/non-IL-17 pathway.

Mark A Kroenke1, Stephen W Chensue, Benjamin M Segal.   

Abstract

Previous studies have shown that EAE can be elicited by the adoptive transfer of either IFN-γ-producing (Th1) or IL-17-producing (Th17) myelin-specific CD4(+) T-cell lines. Paradoxically, mice deficient in either IFN-γ or IL-17 remain susceptible to EAE following immunization with myelin antigens in CFA. These observations raise questions about the redundancy of IFN-γ and IL-17 in autoimmune demyelinating disease mediated by a diverse, polyclonal population of autoreactive T cells. In this study, we show that an atypical form of EAE, induced in C57BL/6 mice by the adoptive transfer of IFN-γ-deficient effector T cells, required IL-17 signaling for the development of brainstem infiltrates. In contrast, classical EAE, characterized by predominant spinal cord inflammation, occurred in the combined absence of IFN-γ and IL-17 signaling, but was dependent on GM-CSF and CXCR2. Our findings contribute to a growing body of data, indicating that individual cytokines vary in their importance across different models of CNS autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20540117      PMCID: PMC2942985          DOI: 10.1002/eji.201040489

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  35 in total

1.  Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes.

Authors:  Amy E Lovett-Racke; Anne E Rocchini; Judy Choy; Sara C Northrop; Rehana Z Hussain; Robert B Ratts; Devanjan Sikder; Michael K Racke
Journal:  Immunity       Date:  2004-11       Impact factor: 31.745

2.  Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.

Authors:  Harald H Hofstetter; Saleh M Ibrahim; Dirk Koczan; Niels Kruse; Andreas Weishaupt; Klaus V Toyka; Ralf Gold
Journal:  Cell Immunol       Date:  2005-12-28       Impact factor: 4.868

3.  Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.

Authors:  Laurie E Harrington; Robin D Hatton; Paul R Mangan; Henrietta Turner; Theresa L Murphy; Kenneth M Murphy; Casey T Weaver
Journal:  Nat Immunol       Date:  2005-10-02       Impact factor: 25.606

4.  IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Authors:  Yutaka Komiyama; Susumu Nakae; Taizo Matsuki; Aya Nambu; Harumichi Ishigame; Shigeru Kakuta; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

5.  IFN-gamma determines distinct clinical outcomes in autoimmune encephalomyelitis.

Authors:  Allen K Wensky; Glaucia C Furtado; Maria Cecilia Garibaldi Marcondes; Shaohua Chen; Denise Manfra; Sergio A Lira; David Zagzag; Juan J Lafaille
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

6.  Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis.

Authors:  D Matusevicius; P Kivisäkk; B He; N Kostulas; V Ozenci; S Fredrikson; H Link
Journal:  Mult Scler       Date:  1999-04       Impact factor: 6.312

7.  IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice.

Authors:  Stefan Haak; Andrew L Croxford; Katharina Kreymborg; Frank L Heppner; Sandrine Pouly; Burkhard Becher; Ari Waisman
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

8.  Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease.

Authors:  Irah L King; Travis L Dickendesher; Benjamin M Segal
Journal:  Blood       Date:  2009-02-05       Impact factor: 22.113

9.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.

Authors:  Claire L Langrish; Yi Chen; Wendy M Blumenschein; Jeanine Mattson; Beth Basham; Jonathan D Sedgwick; Terrill McClanahan; Robert A Kastelein; Daniel J Cua
Journal:  J Exp Med       Date:  2005-01-17       Impact factor: 14.307

10.  GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival.

Authors:  Ivo Sonderegger; Giandomenica Iezzi; Reinhard Maier; Nicole Schmitz; Michael Kurrer; Manfred Kopf
Journal:  J Exp Med       Date:  2008-09-08       Impact factor: 14.307

View more
  62 in total

1.  RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.

Authors:  Laura Codarri; Gabor Gyülvészi; Vinko Tosevski; Lysann Hesske; Adriano Fontana; Laurent Magnenat; Tobias Suter; Burkhard Becher
Journal:  Nat Immunol       Date:  2011-04-24       Impact factor: 25.606

Review 2.  Innate immunity in the central nervous system.

Authors:  Richard M Ransohoff; Melissa A Brown
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

Review 3.  Mechanisms regulating regional localization of inflammation during CNS autoimmunity.

Authors:  Emily Pierson; Sarah B Simmons; Luca Castelli; Joan M Goverman
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

4.  Comparison of a classical Th1 bacteria versus a Th17 bacteria as adjuvant in the induction of experimental autoimmune encephalomyelitis.

Authors:  Alan J Smith; Yue Liu; Haiyan Peng; Rachel Beers; Michael K Racke; Amy E Lovett-Racke
Journal:  J Neuroimmunol       Date:  2011-06-28       Impact factor: 3.478

Review 5.  Th17 cells in autoimmune diseases.

Authors:  Lei Han; Jing Yang; Xiuwen Wang; Dan Li; Ling Lv; Bin Li
Journal:  Front Med       Date:  2015-02-04       Impact factor: 4.592

6.  IFN-γ promotes transendothelial migration of CD4+ T cells across the blood-brain barrier.

Authors:  Sandip Ashok Sonar; Shagufta Shaikh; Nupura Joshi; Ashwini N Atre; Girdhari Lal
Journal:  Immunol Cell Biol       Date:  2017-07-06       Impact factor: 5.126

Review 7.  Cytokine networks in neuroinflammation.

Authors:  Burkhard Becher; Sabine Spath; Joan Goverman
Journal:  Nat Rev Immunol       Date:  2016-12-05       Impact factor: 53.106

8.  T-bet promotes the accumulation of encephalitogenic Th17 cells in the CNS.

Authors:  Heather M Grifka-Walk; Benjamin M Segal
Journal:  J Neuroimmunol       Date:  2016-05-24       Impact factor: 3.478

9.  Autoantibodies to Non-myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis.

Authors:  Michael C Levin; Sangmin Lee; Lidia A Gardner; Yoojin Shin; Joshua N Douglas; Chelsea Cooper
Journal:  J Clin Cell Immunol       Date:  2013-06-30

Review 10.  Modeling the heterogeneity of multiple sclerosis in animals.

Authors:  Sarah B Simmons; Emily R Pierson; Sarah Y Lee; Joan M Goverman
Journal:  Trends Immunol       Date:  2013-05-21       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.